DrugInformer Search

Neurontin Related Respiration abnormal

Official Government Database Reports12
Online Conversations2
Share

Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients. To view the active ingredient report, please click here.


Tell us about your Experience with Neurontin

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Malaise, Agitation, Memory impairment, Aggression, Amnesia, Cough, Dyspnoea, Respiration abnormal, Somnolence, Abasia, Decreased appetite, Suicidal behaviour, Oropharyngeal pain

Posted By Anonymous in askapatient.com on June 2, 2011 @ 12:00 am

Side Effects: Memory loss, agitation, extreme tiredness, sores on mouth and sore throat thought was getting sick so took longer then got so bad that stopped taking med started coughing up skin from t...

Druginformer Identified Side Effects: Dyspnoea, Respiration abnormal

Posted By Anonymous in askapatient.com on December 14, 2009 @ 12:00 am

Side Effects: Difficulties breathing/Dysphnea. Neurontin helped me for almost a month, but ended up with giving me problems breathing. So I had to drop it, unfortunately. Because it gave me...


* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.